Irene Kang - Search Results

Year	Number of Results
2006	1
2007	2
2016	1
2018	1
2019	4
2020	5
2021	9
2022	8
2023	1
2024	2

1

Evaluation of markers of immunity in different metastatic immune microenvironments suggests more suppression within breast to liver metastases in breast cancer.

Hsu R, Al-Zubeidy B, Flores D, Nazarian A, Baugh A, Gonzalez E, Castanon S, Xiu J, Kang I, Spicer D, Lenz HJ, Dara L, Ademuyiwa FO, Korn WM, Irshad S, Chan IS, Roussos Torres ET. Hsu R, et al. Among authors: kang i. Breast Cancer Res Treat. 2024 Apr 20. doi: 10.1007/s10549-024-07295-w. Online ahead of print. Breast Cancer Res Treat. 2024. PMID: 38643348

2

Integrated Proteogenomic Analysis Reveals Distinct Potentially Actionable Therapeutic Vulnerabilities in Triple-Negative Breast Cancer Subtypes.

Kaur P, Ring A, Porras TB, Zhou G, Lu J, Kang I, Lang JE. Kaur P, et al. Among authors: kang i. Cancers (Basel). 2024 Jan 25;16(3):516. doi: 10.3390/cancers16030516. Cancers (Basel). 2024. PMID: 38339267 Free PMC article.

3

Integration of Universal Germline Genetic Testing for All New Breast Cancer Patients.

Culver JO, Freiberg Y, Ricker C, Comeaux JG, Chang EY, Banerjee V, Sturgeon D, Solomon I, Kagey J, Dobre MG, Carey J, Carr A, Cho S, Lu J, Kang IM, Patel K, Terando A, Ye JC, Li M, Lerman C, Spicer D, Nelson M. Culver JO, et al. Among authors: kang im. Ann Surg Oncol. 2023 Feb;30(2):1017-1025. doi: 10.1245/s10434-022-12595-w. Epub 2022 Sep 26. Ann Surg Oncol. 2023. PMID: 36161375 Free PMC article.

4

Correction to: Circulating Tumor Cell Transcriptomics as Biopsy Surrogates in Metastatic Breast Cancer.

Ring A, Campo D, Porras TB, Kaur P, Forte VA, Tripathy D, Lu J, Kang I, Press MF, Jeong YJ, Snow A, Zhu Y, Zada G, Wagle N, Lang JE. Ring A, et al. Among authors: kang i. Ann Surg Oncol. 2022 May;29(5):3064. doi: 10.1245/s10434-022-11589-y. Ann Surg Oncol. 2022. PMID: 35258770 Free PMC article. No abstract available.

5

Disease characterization in liquid biopsy from HER2-mutated, non-amplified metastatic breast cancer patients treated with neratinib.

Shishido SN, Masson R, Xu L, Welter L, Prabakar RK, D' Souza A, Spicer D, Kang I, Jayachandran P, Hicks J, Lu J, Kuhn P. Shishido SN, et al. Among authors: kang i. NPJ Breast Cancer. 2022 Feb 18;8(1):22. doi: 10.1038/s41523-022-00390-5. NPJ Breast Cancer. 2022. PMID: 35181666 Free PMC article.

6

Factors Associated With Hospitalization Among Breast Cancer Patients With COVID-19: A Diverse Multi-Center Los Angeles Cohort Study.

Kathuria-Prakash N, Antrim L, Hornstein N, Sun AW, Kang IM, Baclig NV, Angell TE, Lechner MG, Wald-Dickler N, In GK. Kathuria-Prakash N, et al. Among authors: kang im. Clin Breast Cancer. 2022 Jun;22(4):e558-e566. doi: 10.1016/j.clbc.2021.12.005. Epub 2021 Dec 17. Clin Breast Cancer. 2022. PMID: 35027318 Free PMC article.

7

Circulating Tumor Cell Transcriptomics as Biopsy Surrogates in Metastatic Breast Cancer.

Ring A, Campo D, Porras TB, Kaur P, Forte VA, Tripathy D, Lu J, Kang I, Press MF, Jeong YJ, Snow A, Zhu Y, Zada G, Wagle N, Lang JE. Ring A, et al. Among authors: kang i. Ann Surg Oncol. 2022 May;29(5):2882-2894. doi: 10.1245/s10434-021-11135-2. Epub 2022 Jan 9. Ann Surg Oncol. 2022. PMID: 35000083 Free PMC article.

8

Factors associated with relapse-free survival after neoadjuvant chemotherapy for breast cancer at a safety net medical center.

Sargent RE, Vazquez E, Kang I, Lu J, Manchandia T, Sheth P, Terando A, Nelson ME, Carr A, Hong DS, Sener SF. Sargent RE, et al. Among authors: kang i. Am J Surg. 2022 Mar;223(3):539-542. doi: 10.1016/j.amjsurg.2021.11.017. Epub 2021 Nov 16. Am J Surg. 2022. PMID: 34801227

9

Management of Diarrhea in Patients with HER2-Positive Breast Cancer Treated with Neratinib: A Case Series and Summary of the Literature.

Kruse ML, Kang IM, Bagegni NA, Howell WT, Moore HCF, Bedell CH, Stokoe CT. Kruse ML, et al. Among authors: kang im. Oncol Ther. 2022 Jun;10(1):279-289. doi: 10.1007/s40487-021-00178-w. Epub 2021 Nov 20. Oncol Ther. 2022. PMID: 34800263 Free PMC article.

10

Bariatric surgery in patients with breast and endometrial cancer in California: population-based prevalence and survival.

Lee E, Kawaguchi ES, Zhang J, Kim SE, Deapen D, Liu L, Sheidaee N, Hwang AE, Kang I, Sandhu K, Ursin G, Wu AH, Garcia AA. Lee E, et al. Among authors: kang i. Surg Obes Relat Dis. 2022 Jan;18(1):42-52. doi: 10.1016/j.soard.2021.09.017. Epub 2021 Sep 28. Surg Obes Relat Dis. 2022. PMID: 34740554 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

27 results

Results by year

Search Page

Filters

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

Search Results

27 results

Results by year